Home » Authors » Cormac Sheridan

Articles by Cormac Sheridan

Newron Plans Extended Phase IIb Trial Of Safinamide In Parkinson's

Jan. 15, 2003

By Cormac Sheridan

Elan Names Wall Street Veteran As CEO To Lead Divestiture Plan

Jan. 8, 2003

By Cormac Sheridan

Elan Names Wall Street Veteran As CEO To Lead Divestiture Plan

Jan. 8, 2003

By Cormac Sheridan

Axovan, Biolipox Collaborate On GPCR-Binding Drug Discover

Jan. 1, 2003

By Cormac Sheridan

Axovan, Biolipox Collaborate On GPCR-Binding Drug Discover

Jan. 1, 2003

By Cormac Sheridan

Berna Biotech, Samsung Win Vietnamese Vaccines Project

Dec. 25, 2002

By Cormac Sheridan

Berna Biotech, Samsung Win Vietnamese Vaccines Project

Dec. 25, 2002

By Cormac Sheridan

Pharmexa Moving Pharmaccine For Cancer Into Phase II Studies

Dec. 18, 2002

By Cormac Sheridan

Pharmexa Moving Pharmaccine For Cancer Into Phase II Studies

Dec. 18, 2002

By Cormac Sheridan

Enkam Finalizing First Round, Planning For First Clinical Trial

Dec. 11, 2002

By Cormac Sheridan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...